Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 71
Filter
Add more filters










Publication year range
1.
bioRxiv ; 2023 Feb 01.
Article in English | MEDLINE | ID: mdl-36778425

ABSTRACT

The order Corynebacteriales includes major industrial and pathogenic actinobacteria such as Corynebacterium glutamicum or Mycobacterium tuberculosis . Their elaborate multi-layered cell wall, composed primarily of the mycolyl-arabinogalactan-peptidoglycan complex, and their polar growth mode impose a stringent coordination between the septal divisome, organized around the tubulin-like protein FtsZ, and the polar elongasome, assembled around the tropomyosin-like protein Wag31. Here, we report the identification of two new divisome members, a gephyrin-like repurposed molybdotransferase (GLP) and its membrane receptor (GLPR). We show that the interplay between the GLPR/GLP module, FtsZ and Wag31 is crucial for orchestrating cell cycle progression. Our results provide a detailed molecular understanding of the crosstalk between two essential machineries, the divisome and elongasome, and reveal that Corynebacteriales have evolved a protein scaffold to control cell division and morphogenesis similar to the gephyrin/GlyR system that in higher eukaryotes mediates synaptic signaling through network organization of membrane receptors and the microtubule cytoskeleton.

2.
Biochem Soc Trans ; 35(Pt 5): 1321-4, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17956342

ABSTRACT

The need for better drugs to treat tuberculosis has never been greater. Despite insufficient funding for discovery research, intensive efforts have been made to find and develop new lead compounds capable of reducing the duration of the present treatment known as DOTS (directly observed therapy short course), from 6 to under 4 months. This minireview describes the progress achieved during the last 5 years and highlights some of the successes without neglecting the problems.


Subject(s)
Antitubercular Agents/therapeutic use , Antitubercular Agents/chemistry , Antitubercular Agents/classification , Drug Design , Humans , Tuberculosis/drug therapy
3.
Acta Crystallogr D Biol Crystallogr ; 62(Pt 10): 1196-207, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17001096

ABSTRACT

The Structural Proteomics In Europe (SPINE) programme is aimed at the development and implementation of high-throughput technologies for the efficient structure determination of proteins of biomedical importance, such as those of bacterial and viral pathogens linked to human health. Despite the challenging nature of some of these targets, 175 novel pathogen protein structures (approximately 220 including complexes) have been determined to date. Here the impact of several technologies on the structural determination of proteins from human pathogens is illustrated with selected examples, including the parallel expression of multiple constructs, the use of standardized refolding protocols and optimized crystallization screens.


Subject(s)
Bacterial Infections/metabolism , Bacterial Proteins/chemistry , Proteomics/methods , Viral Proteins/chemistry , Virus Diseases/metabolism , Animals , Bacterial Infections/microbiology , Humans , Protein Folding , Virus Diseases/virology
4.
Acta Crystallogr D Biol Crystallogr ; 62(Pt 10): 1184-95, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17001095

ABSTRACT

SPINE (Structural Proteomics In Europe) was established in 2002 as an integrated research project to develop new methods and technologies for high-throughput structural biology. Development areas were broken down into workpackages and this article gives an overview of ongoing activity in the bioinformatics workpackage. Developments cover target selection, target registration, wet and dry laboratory data management and structure annotation as they pertain to high-throughput studies. Some individual projects and developments are discussed in detail, while those that are covered elsewhere in this issue are treated more briefly. In particular, this overview focuses on the infrastructure of the software that allows the experimentalist to move projects through different areas that are crucial to high-throughput studies, leading to the collation of large data sets which are managed and eventually archived and/or deposited.


Subject(s)
Computational Biology/statistics & numerical data , Proteomics/statistics & numerical data , Crystallization , Data Interpretation, Statistical , Information Management , Reverse Transcriptase Polymerase Chain Reaction , Software
5.
J Mol Biol ; 350(5): 953-63, 2005 Jul 29.
Article in English | MEDLINE | ID: mdl-15978616

ABSTRACT

Genes for functional Ser/Thr protein kinases (STPKs) are ubiquitous in prokaryotic genomes, but little is known about their physiological substrates and their actual involvement in bacterial signal transduction pathways. We report here the identification of GarA (Rv1827), a Forkhead-associated (FHA) domain-containing protein, as a putative physiological substrate of PknB, an essential Ser/Thr protein kinase from Mycobacterium tuberculosis. Using a global proteomic approach, GarA was found to be the best detectable substrate of the PknB catalytic domain in non-denatured whole-cell protein extracts from M. tuberculosis and the saprophyte Mycobacterium smegmatis. Enzymological and binding studies of the recombinant proteins demonstrate that docking interactions between the activation loop of PknB and the C-terminal FHA domain of GarA are required to enable efficient phosphorylation at a single N-terminal threonine residue, Thr22, of the substrate. The predicted amino acid sequence of the garA gene, including both the N-terminal phosphorylation motif and the FHA domain, is strongly conserved in mycobacteria and other related actinomycetes, suggesting a functional role of GarA in putative STPK-mediated signal transduction pathways. The ensuing model of PknB-GarA interactions suggests a substrate recruitment mechanism that might apply to other mycobacterial kinases bearing multiple phosphorylation sites in their activation loops.


Subject(s)
Intracellular Signaling Peptides and Proteins/metabolism , Mycobacterium tuberculosis/chemistry , Protein Kinases/metabolism , Protein Serine-Threonine Kinases/metabolism , Amino Acid Sequence , Phosphorylation , Protein Binding , Protein Serine-Threonine Kinases/physiology , Proteomics/methods , Signal Transduction , Substrate Specificity
6.
Acta Crystallogr D Biol Crystallogr ; 58(Pt 10 Pt 2): 1780-6, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12351821

ABSTRACT

Three-beam interference experiments have been performed with crystals of two glycosidases: guinea-fowl hexagonal lysozyme, MW 14.3 kDa, and C. thermocellum endoglucanase CelA, MW 40 kDa. In both cases triplet phases could be estimated. Experimental parameters and details of the procedure are presented along with some examples of the results. The average differences between the estimated phases and those calculated from the crystallographic refinements were 17.9 and 15.9 degrees, respectively. A brief discussion of alternative methods for physical phase acquisition is given, including possible strategies for the measurement and application of experimental phases in macromolecular crystallography.


Subject(s)
Cellulase/chemistry , Muramidase/chemistry , Animals , Birds , Clostridium/enzymology , Crystallography, X-Ray/methods , Phosphoenolpyruvate Sugar Phosphotransferase System/chemistry
7.
Cell Mol Biol (Noisy-le-grand) ; 47(4): 703-7, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11502078

ABSTRACT

Human interleukin-2 (IL-2) interacts with two types of functional receptors (IL-2R alpha betagamma and IL-2R betagamma) and acts on a broad range of target cells involved in inflammatory reactions and immune responses. IL-2 is also used in different clinical trials aimed at improving the treatment of some cancers and the recovery of CD4 lymphocytes by HIV patients. The therapeutic index of IL-2 is limited by various side effects dominated by the vascular leak syndrome. We have shown that a chemically synthesised fragment of the IL-2 sequence can fold into a helical tetramer likely mimicking the quatemary structure of an hemopoietin. Indeed, peptide p1-30 (containing amino acids 1 to 30, including the sequence corresponding to the entire alpha helix A of IL-2) spontaneously folds into an alpha-helical homotetramer and stimulates the growth of T-cell lines expressing human IL-2R beta, whereas shorter versions of the peptide lack helical structure and are inactive. At the cellular level, p1-30 induces lymphokine-activated killer (LAK) cells and preferentially activates CD8 low lymphocytes and natural killer cells, which constitutively express IL-2R beta. A significant IFN-gamma production is also detected following p1-30 stimulation. A mutant form of p1-30 (Asp20-->Lys) which is likely unable to induce vascular leak syndrome remains capable to generate LAK cells like the original p1-30 peptide. Altogether our data suggest that p1-30 has therapeutic potential.


Subject(s)
Interleukin-2/analogs & derivatives , Interleukin-2/therapeutic use , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/immunology , Humans , Interleukin-2/agonists , Interleukin-2/physiology , Killer Cells, Lymphokine-Activated/drug effects , Killer Cells, Lymphokine-Activated/immunology , Killer Cells, Natural/drug effects , Killer Cells, Natural/immunology , Molecular Structure , Peptide Fragments/chemistry , Peptide Fragments/therapeutic use , Receptors, Interleukin-2/drug effects , Receptors, Interleukin-2/physiology , Signal Transduction
8.
Glycobiology ; 11(4): 305-11, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11358879

ABSTRACT

Sialidases are present on the surface of several trypanosomatid protozoan parasites. They are highly specific for sialic acid linked in alpha-(2,3) to a terminal beta-galactose and include the strictly hydrolytic enzymes and trans-sialidases (sialyl-transferases). Based on the structural comparison of the sialidase from Trypanosoma rangeli and the trans-sialidase from T. cruzi (the agent of Chagas' disease in humans), we have explored the role of specific amino acid residues sought to be important for substrate specificity. The substitution of a conserved tryptophanyl residue in the two enzymes, Trp312/313-Ala, changed substrate specificity, rendering the point mutants capable to hydrolyze both alpha-(2,3)- and alpha-(2,6)-linked sialoconjugates. The same mutation abolished sialyl-transferase activity, indicating that transfer (but not hydrolysis) requires a precise orientation of the bound substrate. The exchange substitution of another residue that modulates oligosaccharide binding, Gln284-Pro, was found to significantly increase the hydrolytic activity of sialidase, and residue Tyr119 was confirmed to be part of a second binding site for the acceptor substrate in trans-sialidase. Together with the structural information, these results provide a consistent framework to account for the unique enzymatic properties of trypanosome trans-sialidases.


Subject(s)
Neuraminidase/chemistry , Neuraminidase/metabolism , Point Mutation/genetics , Trypanosoma/enzymology , Amino Acid Substitution/genetics , Amino Acids/analysis , Animals , Binding Sites , Binding, Competitive , Hydrolysis , Models, Molecular , Mutagenesis, Site-Directed , Neuraminidase/genetics , Protein Conformation , Substrate Specificity , Trypanosoma/genetics
9.
Infect Immun ; 69(3): 1869-75, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11179365

ABSTRACT

Trypanosoma cruzi, the agent of Chagas' disease, expresses trans-sialidase, a unique enzyme activity that enables the parasite to invade host cells by transferring sialyl residues from host glyconjugates to the parasite's surface acceptor molecules. The enzyme is also shed into the surrounding environment, causing apoptosis in cells from the immune system. During infections, an antibody response against the catalytic region of the trans-sialidase that is coincident with the control of the parasitemia and survival of the host is observed. This low-titer humoral response is characterized by its persistence for many years in benznidazole-treated patients. Here we analyzed the antigenic structure of the molecule by phage-displayed peptide combinatorial libraries and SPOT synthesis. Several epitopes were defined and located on the three-dimensional model of the enzyme. Unexpectedly, cross-reaction was found among several epitopes distributed in different locations displaying nonconsensus sequences. This finding was confirmed by the reactivity of three monoclonal antibodies able to recognize non-sequence-related peptides that together constitute the surface surrounding the catalytic site of the enzyme. The presence of cross-reacting epitopes within a single molecule suggests a mechanism developed to avoid a strong humoral response by displaying an undefined target to the immune system.


Subject(s)
Antigens, Protozoan/immunology , Glycoproteins/immunology , Neuraminidase/immunology , Trypanosoma cruzi/immunology , Amino Acid Sequence , Animals , Antibodies, Monoclonal , Antibodies, Protozoan , Catalytic Domain/immunology , Cross Reactions , Epitope Mapping , Epitopes , Mice , Mice, Inbred BALB C , Models, Molecular , Molecular Sequence Data , Peptide Library
10.
Eur J Immunol ; 30(12): 3387-95, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11093156

ABSTRACT

Four different monoclonal Ig (MIg) (IgA1kappa, IgG1kappa, IgG2kappa and IgG4kappa) displaying anti-tubulin activity were detected in the serum from a lymphoma patient. The complete sequence of three of these MIg showed identical V(H) and V(L) domains and the presence of mutations compatible with an antigen-driven process. Surprisingly, despite complete homology in their variable domains, IgA1kappa, IgG1kappa, or their Fab fragments bound to a common motif recognized in beta tubulin, with significant differences in affinity (IgA1kappa 1.52x10(-8) M, and IgG1kappa 2.09x10(-7) M). To substantiate these results, the V(H) and V(L) domains from IgA1kappa were cloned and introduced into expression vectors containing the constant kappa exon and either the mu or the gamma1 constant exon, and complete recombinant IgMkappa and IgG1kappa were obtained. Like the IgA1kappa, the IgMkappa construction bound to the tubulin epitope with consistent affinity (7.7x10(-9) M), whereas the IgG1kappa construction displayed a significantly lower affinity (3.28x10(-7) M). These results provide definitive evidence that isotype can influence binding affinity to antigen and suggest that malignant transformation occurred at the germinal center once the mutational process was achieved and the switch process was still active.


Subject(s)
Antigen-Antibody Reactions , Immunoglobulin Class Switching , Amino Acid Sequence , Base Sequence , Epitopes , Humans , Immunoglobulin A/immunology , Immunoglobulin G/classification , Immunoglobulin G/immunology , Immunoglobulin Heavy Chains/chemistry , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Light Chains/chemistry , Immunoglobulin Light Chains/genetics , Immunoglobulin Variable Region/chemistry , Immunoglobulin Variable Region/genetics , Molecular Sequence Data , Surface Plasmon Resonance , Tubulin/immunology
11.
Hybridoma ; 19(3): 229-39, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10952411

ABSTRACT

In this work, we have constructed two functional mouse/human chimeric antibodies (IgMkappa and IgG1kappa isotypes) by inserting genomic DNA fragments encoding VH and Vkappa variable regions of the murine monoclonal antibody IgMK-83D4 into mammalian expression vectors containing human mu, gamma1, and kappa constant exons, and by transfecting them into the nonsecreting mouse myeloma X-63 cell line. In previous works, we have demonstrated that 83D4 murine mAb reacts with Tn determinant (GalNAcalpha-O-Ser/Thr) expressed in 90% of breast, ovary, and colon carcinomas. Both expressed chimeric antibodies were purified from the transfected cell line supernatant by affinity chromatography, and their reactivities against Tn antigen were confirmed by ELISA on asialo ovine submaxilar mucin and immunofluorescence studies on MCF-7 breast carcinoma cell line. We have demonstrated by gel filtration chromatography, that the principal secreted forms were monomers for IgG1kappa and pentamers for IgMkappa. The binding affinities of these chimeric antibodies against synthetic Tn glycopeptides, were evaluated by surface plasmon resonance showing an affinity constant similar to that of 83D4 native antibody for IgMkappa and a lower affinity constant for IgG1kappa chimeric antibody. On the other hand, the replacement of mouse C regions with human C regions confers both chimeric antibodies the ability to activate human complement. These mouse/human chimeric antibodies should be much less immunogenic and could play an important role in the lysis of tumor cell expressing Tn-antigen. Therefore, these anti-Tn chimeric antibodies could be considered as potential tools for human in vivo studies.


Subject(s)
Antibodies, Monoclonal/chemistry , Antibodies, Monoclonal/genetics , Antibody Specificity/genetics , Antigens, Tumor-Associated, Carbohydrate/immunology , Antigens, Tumor-Associated, Carbohydrate/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Animals , Antibodies, Monoclonal/isolation & purification , Cell Fusion , Genetic Vectors , Humans , Hybridomas/metabolism , Immunoglobulin G/biosynthesis , Immunoglobulin G/genetics , Immunoglobulin Heavy Chains/genetics , Immunoglobulin Heavy Chains/isolation & purification , Immunoglobulin Light Chains/genetics , Immunoglobulin Light Chains/isolation & purification , Immunoglobulin M/biosynthesis , Immunoglobulin M/genetics , Immunoglobulin kappa-Chains/genetics , Immunoglobulin kappa-Chains/isolation & purification , Mice , Mice, Inbred C57BL , Recombinant Fusion Proteins/immunology , Transfection , Tumor Cells, Cultured
12.
Proc Natl Acad Sci U S A ; 97(15): 8433-8, 2000 Jul 18.
Article in English | MEDLINE | ID: mdl-10880560

ABSTRACT

The crystal structure of the murine Fab S-20-4 from a protective anti-cholera Ab specific for the lipopolysaccharide Ag of the Ogawa serotype has been determined in its unliganded form and in complex with synthetic fragments of the Ogawa O-specific polysaccharide (O-SP). The upstream terminal O-SP monosaccharide is shown to be the primary antigenic determinant. Additional perosamine residues protrude outwards from the Ab surface and contribute only marginally to the binding affinity and specificity. A complementary water-excluding hydrophobic interface and five Ab-Ag hydrogen bonds are crucial for carbohydrate recognition. The structure reported here explains the serotype specificity of anti-Ogawa Abs and provides a rational basis toward the development of a synthetic carbohydrate-based anti-cholera vaccine.


Subject(s)
Antibodies, Bacterial/chemistry , Antibodies, Monoclonal/chemistry , Antigens, Bacterial/immunology , Lipopolysaccharides/immunology , Vibrio cholerae/immunology , Animals , Antibodies, Bacterial/immunology , Antibodies, Monoclonal/immunology , Antibody Specificity/immunology , Antigen-Antibody Reactions/immunology , Carbohydrate Sequence , Crystallography, X-Ray , Immunoglobulin Fab Fragments/chemistry , Immunoglobulin Fab Fragments/immunology , Lipopolysaccharides/chemistry , Mice , Models, Molecular , Molecular Sequence Data , Protein Conformation , Serotyping , Structure-Activity Relationship
13.
J Biol Chem ; 275(28): 21572-7, 2000 Jul 14.
Article in English | MEDLINE | ID: mdl-10787420

ABSTRACT

The three-dimensional structure of the major horse allergen Equ c 1 has been determined at 2.3 A resolution by x-ray crystallography. Equ c 1 displays the typical fold of lipocalins, a beta-barrel flanked by a C-terminal alpha-helix. The space between the two beta-sheets of the barrel defines an internal cavity that could serve, as in other lipocalins, for the binding and transport of small hydrophobic ligands. Equ c 1 crystallizes in a novel dimeric form, which is distinct from that observed in other lipocalin dimers and corresponds to the functional form of the allergen. Binding studies of point mutants of the allergen with specific monoclonal antibodies raised in mouse and IgE serum from horse allergic patients allowed to identify putative B cell antigenic determinants. In addition, total inhibition of IgE serum recognition by a single specific monoclonal antibody revealed the restricted nature of the IgE binding target on the molecular surface of Equ c 1.


Subject(s)
Allergens/chemistry , Glycoproteins/chemistry , Allergens/immunology , Amino Acid Sequence , Animals , Antibodies, Monoclonal/chemistry , Binding Sites , Carrier Proteins/chemistry , Crystallography, X-Ray , Dimerization , Glycoproteins/immunology , Horses , Immunoglobulin E/blood , Immunoglobulin E/immunology , Lipocalins , Mice , Models, Molecular , Molecular Sequence Data , Mutagenesis, Site-Directed , Point Mutation , Protein Conformation , Protein Structure, Secondary , Recombinant Proteins/chemistry , Recombinant Proteins/immunology , Sequence Alignment , Sequence Homology, Amino Acid
14.
FEBS Lett ; 469(1): 24-8, 2000 Mar 03.
Article in English | MEDLINE | ID: mdl-10708749

ABSTRACT

Using synthetic Tn (GalNAc-O-Ser/Thr) glycopeptide models and a biosensor based on surface plasmon resonance spectroscopy we have determined that isolectin B4 from Vicia villosa (VVLB4) binds to one Tn determinant whereas the anti-Tn monoclonal antibodies 83D4 and MLS128 require at least two Tn residues for recognition. When an unglycosylated amino acid is introduced between the Tn residues, both antibodies do not bind. MLS128 affinity was higher on a glycopeptide with three consecutive Tn residues. These results indicate that Tn residues organized in clusters are essential for the binding of these antibodies and indicate a different Tn recognition pattern for VVLB4.


Subject(s)
Antigens, Tumor-Associated, Carbohydrate/immunology , Plant Lectins , Animals , Antibodies, Monoclonal/immunology , Antigens, Tumor-Associated, Carbohydrate/chemistry , Biomarkers, Tumor/immunology , Biosensing Techniques , Epitopes/chemistry , Glycopeptides/chemical synthesis , Glycopeptides/immunology , Glycosylation , Kinetics , Lectins/immunology , Mice , Protein Binding , Surface Plasmon Resonance
15.
J Exp Med ; 191(3): 529-40, 2000 Feb 07.
Article in English | MEDLINE | ID: mdl-10662798

ABSTRACT

Interleukin (IL)-2 interacts with two types of functional receptors (IL-2Ralphabetagamma and IL-2Rbetagamma) and acts on a broad range of target cells involved in inflammatory reactions and immune responses. For the first time, we show that a chemically synthesized fragment of the IL-2 sequence can fold into a molecule mimicking the quaternary structure of a hemopoietin. Indeed, peptide p1-30 (containing amino acids 1-30, covering the entire alpha helix A of IL-2) spontaneously folds into an alpha-helical homotetramer and stimulates the growth of T cell lines expressing human IL-2Rbeta, whereas shorter versions of the peptide lack helical structure and are inactive. We also demonstrate that this neocytokine interacts with a previously undescribed dimeric form of IL-2Rbeta. In agreement with its binding to IL-2Rbeta, p1-30 activates Shc and p56(lck) but unlike IL-2, fails to activate Janus kinase (Jak)1, Jak3, and signal transducer and activator of transcription 5 (STAT5). Unexpectedly, we also show that p1-30 activates Tyk2, thus suggesting that IL-2Rbeta may bind to different Jaks depending on its oligomerization. At the cellular level, p1-30 induces lymphokine-activated killer (LAK) cells and preferentially activates CD8(low) lymphocytes and natural killer cells, which constitutively express IL-2Rbeta. A significant interferon gamma production is also detected after p1-30 stimulation. A mutant form of p1-30 (Asp20-->Lys), which is likely unable to induce vascular leak syndrome, remains capable of generating LAK cells, like the original p1-30 peptide. Altogether, our data suggest that p1-30 has therapeutic potential.


Subject(s)
Interleukin-2/pharmacology , Killer Cells, Lymphokine-Activated/metabolism , Receptors, Interleukin-2/agonists , Amino Acid Sequence , Animals , Binding Sites , CD8-Positive T-Lymphocytes/metabolism , Cell Line , Enzyme Activation/drug effects , Humans , Interferon-gamma/analysis , Interleukin-2/chemistry , Interleukin-2/genetics , Lymphocyte Activation/drug effects , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/metabolism , Lymphocyte Subsets/metabolism , Mice , Molecular Sequence Data , Monocytes/drug effects , Peptide Fragments/chemistry , Peptide Fragments/pharmacology , Protein Folding , Receptors, Interleukin-2/antagonists & inhibitors , Receptors, Interleukin-2/metabolism , Signal Transduction , src Homology Domains
16.
Eur J Biochem ; 267(5): 1434-40, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10691981

ABSTRACT

SSL, the lectin isolated from Salvia sclarea seeds, recognizes the Tn antigen (GalNAcalpha-O-Ser/Thr), a specific marker of many human carcinomas. Two-dimensional electrophoresis, amino-acid and amino-sugar analysis, and MALDI-TOF MS showed that SSL is an acidic (pI 5.5), 60-61-kDa dimeric glycoprotein composed of apparently identical subunits linked by a single disulfide bond. The apparent molecular mass of SSL in solution determined by equilibrium sedimentation analytical ultracentrifugation was 59 +/- 9 kDa. This value did not change in the pH range 2.5-8.5, indicating that SSL does not associate into higher order structures. Tandem mass spectrometry and methylation analysis of N-glycans released from SSL by hydrazinolysis indicated that SSL possesses 2-3 glycosylation sites occupied with the typical plant glycans Manalpha1-6[(Manalpha1-3)(Xylbeta1-2)]Manbeta1-4 -GlcNAcbeta1-4(Fucalp ha1-3)GlcNAc and [(Manalpha1-3/6)(Xylbeta1-2)]Manbeta1-4-GlcNAcbeta1 -4(Fucalpha1-3)Glc NAc. The influence of adjacent Tn structures on the binding of two Tn-specific lectins (SSL and the isolectin B4 from Vicia villosa) and an anti-Tn monoclonal antibody (mAb 83D4) was evaluated using synthetic Tn glycopeptides. The binding of both lectins to the synthetic Tn glycopeptides was independent of the density of Tn structures. On the other hand, mAb 83D4 only reacted with glycopeptides displaying two or three consecutive Tn structures.


Subject(s)
Antigens, Tumor-Associated, Carbohydrate/metabolism , Lectins/metabolism , Plants/metabolism , Seeds/metabolism , Antibodies, Monoclonal/immunology , Carbohydrate Conformation , Carbohydrate Sequence , Dimerization , Disulfides/chemistry , Epitopes/immunology , Glycopeptides/chemistry , Glycopeptides/metabolism , Lectins/chemistry , Lectins/immunology , Molecular Sequence Data , Plant Lectins , Plants/embryology
17.
EMBO J ; 19(1): 16-24, 2000 Jan 04.
Article in English | MEDLINE | ID: mdl-10619840

ABSTRACT

The intracellular parasite Trypanosoma cruzi, the etiological agent of Chagas disease, sheds a developmentally regulated surface trans-sialidase, which is involved in key aspects of parasite-host cell interactions. Although it shares a common active site architecture with bacterial neuraminidases, the T.cruzi enzyme behaves as a highly efficient sialyltransferase. Here we report the crystal structure of the closely related Trypanosoma rangeli sialidase and its complex with inhibitor. The enzyme folds into two distinct domains: a catalytic beta-propeller fold tightly associated with a lectin-like domain. Comparison with the modeled structure of T.cruzi trans-sialidase and mutagenesis experiments allowed the identification of amino acid substitutions within the active site cleft that modulate sialyltransferase activity and suggest the presence of a distinct binding site for the acceptor carbohydrate. The structures of the Trypanosoma enzymes illustrate how a glycosidase scaffold can achieve efficient glycosyltransferase activity and provide a framework for structure-based drug design.


Subject(s)
Neuraminidase/metabolism , Sialyltransferases/metabolism , Trypanosoma/enzymology , Animals , Binding Sites , Crystallography, X-Ray , Models, Molecular , Mutagenesis, Site-Directed , Neuraminidase/genetics , Protein Conformation , Sialyltransferases/genetics , Trypanosoma/genetics
18.
Proc Natl Acad Sci U S A ; 96(11): 6445-50, 1999 May 25.
Article in English | MEDLINE | ID: mdl-10339607

ABSTRACT

The process of human erythrocyte invasion by Plasmodium falciparum parasites involves a calcium-dependent serine protease with properties consistent with a subtilisin-like activity. This enzyme achieves the last crucial maturation step of merozoite surface protein 1 (MSP1) necessary for parasite entry into the host erythrocyte. In eukaryotic cells, such processing steps are performed by subtilisin-like maturases, known as proprotein convertases. In an attempt to characterize the MSP1 maturase, we have identified a gene that encodes a P. falciparum subtilisin-like protease (PfSUB2) whose deduced active site sequence resembles more bacterial subtilisins. Therefore, we propose that PfSUB2 belongs to a subclass of eukaryotic subtilisins different from proprotein convertases. Pfsub2 is expressed during merozoite differentiation and encodes an integral membrane protein localized in the merozoite dense granules, a secretory organelle whose contents are believed to participate in a late step of the erythrocyte invasion. PfSUB2's subcellular localization, together with its predicted enzymatic properties, leads us to propose that PfSUB2 could be responsible for the late MSP1 maturation step and thus is an attractive target for the development of new antimalarial drugs.


Subject(s)
Merozoite Surface Protein 1/metabolism , Plasmodium falciparum/enzymology , Plasmodium falciparum/genetics , Subtilisins/genetics , Subtilisins/metabolism , Amino Acid Sequence , Animals , Binding Sites , Catalytic Domain , Erythrocytes/parasitology , Humans , Molecular Sequence Data , Phylogeny , Plasmodium falciparum/pathogenicity , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Subtilisins/chemistry
19.
Protein Sci ; 8(4): 934-40, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10211841

ABSTRACT

The enzymes carbamoyl phosphate synthetase (CPS) and carbamate kinase (CK) make carbamoyl phosphate in the same way: by ATP-phosphorylation of carbamate. The carbamate used by CK is made chemically, whereas CPS itself synthesizes its own carbamate in a process involving the phosphorylation of bicarbonate. Bicarbonate and carbamate are analogs and the phosphorylations are carried out by homologous 40 kDa regions of the 120 kDa CPS polypeptide. CK can also phosphorylate bicarbonate and is a homodimer of a 33 kDa subunit that was believed to resemble the 40 kDa regions of CPS. Such belief is disproven now by the CK structure reported here. The structure does not conform to the biotin carboxylase fold found in the 40 kDa regions of CPS, and presents a new type of fold possibly shared by homologous acylphosphate-making enzymes. A molecular 16-stranded open beta-sheet surrounded by alpha-helices is the hallmark of the CK dimer. Each subunit also contains two smaller sheets and a large crevice found at the location expected for the active center. Intersubunit interactions are very large and involve a central hydrophobic patch and more hydrophilic peripheral contacts. The crevice holds a sulfate that may occupy the site of an ATP phosphate, and is lined by conserved residues. Site-directed mutations tested at two of these residues inactivate the enzyme. These findings support active site location in the crevice. The orientation of the crevices in the dimer precludes their physical cooperation in the catalytic process. Such cooperation is not needed in the CK reaction but is a requirement of the mechanism of CPSs.


Subject(s)
Arginine/biosynthesis , Carbamyl Phosphate/chemistry , Phosphotransferases (Carboxyl Group Acceptor)/chemistry , Pyrimidines/biosynthesis , Crystallography, X-Ray , Enterococcus faecium/enzymology , Models, Molecular , Mutagenesis, Site-Directed , Protein Structure, Secondary
20.
Acta Crystallogr D Biol Crystallogr ; 55(Pt 4): 880-2, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10089322

ABSTRACT

The secreted protein Equ c 1 is the major component responsible for the induction of specific IgE antibodies in patients sensitized to horse allergens. Equ c 1 belongs to the lipocalin superfamily of hydrophobic ligand-binding proteins, which also includes other known allergens. Equilibrium sedimentation and gel-filtration studies demonstrate that both the glycosylated form of Equ c 1 purified from horse salivary glands and the non-glycosylated recombinant form expressed in bacteria exist predominantly as dimers in solution. As observed for other dimeric lipocalins, acidic pH and low protein concentration favour dimer dissociation. The recombinant form of Equ c 1 has been crystallized using ammonium sulfate as a precipitant. The crystals belong to the tetragonal space group P41212 with cell parameters a = b = 84.0, c = 56.1 A, and contain a single molecule in the asymmetric unit. A complete data set from native crystals was collected at the synchrotron source in Hamburg to 2.9 A resolution using a frozen crystal, and structure determination is in progress.


Subject(s)
Allergens/chemistry , Glycoproteins/chemistry , Horses/immunology , Allergens/genetics , Allergens/isolation & purification , Animals , Crystallization , Crystallography, X-Ray , Dimerization , Glycoproteins/genetics , Glycoproteins/isolation & purification , Lipocalins , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...